まとめ
インド インド インド インド.
科学分野:
- 医薬品科学 医薬品科学について
- 薬物の発見と開発
- グローバル・ヘルス・ポリシー
背景:
- ジェネリック医薬品の主要メーカーとしてのインドの確立した役割.
- インドの製薬会社とアメリカ/ヨーロッパの大手企業との間の新たな協力関係.
- インドにおける医薬品イノベーションの発展の様子.
研究 の 目的:
- インドの薬剤発見能力に対する国際協力の影響を分析する.
- インドにおける医薬品イノベーションに影響を与える規制環境を調査する.
- インドの製薬会社の新薬開発への移行を理解する.
主な方法:
- 最近の製薬業界のパートナーシップと同盟のレビュー.
- インドの特許,医薬品承認,臨床試験に関する規制枠組みの分析.
- 革新的な薬剤発見に携わるインド企業のケーススタディ.
主要な成果:
- インドの製薬会社は,ますますグローバル大企業と提携しています.
- これらのコラボレーションは,革新的な薬剤発見への移行を促進しています.
- 規制の更新は継続しており,特許,承認,試験プロセスに影響を及ぼしています.
結論:
- 国際的な同盟は,革新的な薬剤発見におけるインドの進歩にとって不可欠です.
- 変化する規制環境は,機会と課題の両方を提示しています.
- 規制の継続的な適応は,医薬品のイノベーションの持続的な成長に不可欠です.
関連する概念動画
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
01:02Prescription, Nonprescription and Orphan Drugs
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
01:28Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
01:26Pharmaceutical Equivalents
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
01:09Bioequivalence of Drugs: Drugs with Multiple Indications
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each indication due to...
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...